- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04357132
Virtual Reality for Appendectomy Pain
February 6, 2023 updated by: Children's Hospital Medical Center, Cincinnati
Functional Response to Immersive Virtual Reality in Pediatric Patients Post-Laparoscopic Appedectomy
To determine the impact of VR-Biofeedback and VR-Distraction on pain and medication utilization in children and adolescents undergoing surgery for ruptured appendix.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
15
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Cincinnati, Ohio, United States, 45229
- Cincinnati Children's Hospital Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
8 years to 18 years (ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 8 - 18 years
- Able to read, understand, and speak English
- Patients in the immediate postoperative period following laparoscopic appendectomy for ruptured appendix
Exclusion Criteria:
- Outside of age range (<8 or >18 years)
- History of developmental delays, uncontrolled psychiatric conditions, or neurological conditions (especially epilepsy and/or significant motion sickness/nausea/vomiting)
- History of vertigo, dizziness, and/or seizure disorders
- Conditions that would preclude the application of the VR headset, such as craniofacial deformities
- History of chronic pain, frequent opioid use and/or active cancer therapy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: VR-Biofeedback
|
Participants will be instructed to use the Mindful Aurora Application
|
OTHER: VR-Distraction
|
Participants will be instructed to use one of four applications
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Effect of VR-biofeedback on pain
Time Frame: Postoperatively 24 - 90 hours.
|
Pain scores will be collected.
Pain will be rated using the numerical rating scale.
Participant will rate their pain from 0 - 10. 0 meaning no pain and 10 being the worst pain imaginable.
|
Postoperatively 24 - 90 hours.
|
Effect of VR-distraction on pain
Time Frame: Postoperatively 24 - 90 hours.
|
Pain scores will be collected.
Pain will be rated using the numerical rating scale.
Participant will rate their pain from 0 - 10. 0 meaning no pain and 10 being the worst pain imaginable.
|
Postoperatively 24 - 90 hours.
|
Effect on VR-biofeedback on anxiety
Time Frame: Before 10 minute VR session.
|
Anxiety scores will be collected.
Anxiety will be rated using a visual analog scale.
Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety.
|
Before 10 minute VR session.
|
Effect on VR-biofeedback on anxiety
Time Frame: Immediately after VR session.
|
Anxiety scores will be collected.
Anxiety will be rated using a numerical rating scale.
Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety.
|
Immediately after VR session.
|
Effect on VR-biofeedback on anxiety
Time Frame: 15 minutes after VR session.
|
Anxiety scores will be collected.
Anxiety will be rated using a numerical rating scale.
Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety.
|
15 minutes after VR session.
|
Effect on VR-biofeedback on anxiety
Time Frame: 30 minutes after VR session.
|
Anxiety scores will be collected.
Anxiety will be rated using a numerical rating scale.
Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety.
|
30 minutes after VR session.
|
Effect of VR-biofeedback on medication use
Time Frame: 24-90 hours
|
Amount of pain medications used will be collected
|
24-90 hours
|
Effect of VR-distraction on anxiety
Time Frame: Before 10 minute VR session.
|
Anxiety scores will be collected.
Anxiety will be rated using a numerical rating scale.
Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety.
|
Before 10 minute VR session.
|
Effect of VR-distraction on anxiety
Time Frame: Immediately after 10 minute VR session.
|
Anxiety scores will be collected.
Anxiety will be rated using a numerical rating scale.
Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety.
|
Immediately after 10 minute VR session.
|
Effect of VR-distraction on anxiety
Time Frame: 15 minutes after 10 minute VR session.
|
Anxiety scores will be collected.
Anxiety will be rated using a numerical rating scale.
Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety.
|
15 minutes after 10 minute VR session.
|
Effect of VR-distraction on anxiety
Time Frame: 30 minutes after 10 minute VR session.
|
Anxiety scores will be collected.
Anxiety will be rated using a numerical rating scale.
Anxiety will be rated from 0 - 10. 0 meaning no anxiety 10 being severe anxiety.
|
30 minutes after 10 minute VR session.
|
Effect of VR-distraction on medication use
Time Frame: 24-90 hours
|
Pain medications used will be collected
|
24-90 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Role of anxiety on changes in pain
Time Frame: One time prior to study visit
|
Participants will complete a questionnaire regarding anxiety
|
One time prior to study visit
|
Role of pain catastrophizing
Time Frame: One time prior to study visit
|
Participants will complete a questionnaire regarding pain
|
One time prior to study visit
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Vanessa Olbrecht, MD, Children's Hospital Medical Center, Cincinnati
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
July 12, 2020
Primary Completion (ACTUAL)
August 30, 2021
Study Completion (ACTUAL)
August 30, 2021
Study Registration Dates
First Submitted
April 17, 2020
First Submitted That Met QC Criteria
April 21, 2020
First Posted (ACTUAL)
April 22, 2020
Study Record Updates
Last Update Posted (ACTUAL)
February 8, 2023
Last Update Submitted That Met QC Criteria
February 6, 2023
Last Verified
February 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020-0258
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain
-
Flowonix MedicalApproved for marketingBack Pain | Leg Pain | Trunk Pain | Intractable Pain | Arm Pain
-
University Hospital Schleswig-HolsteinZealand University Hospital; European Regional Development Fund; Design School...CompletedPain, Acute | Pain, Chronic | Pain Measurement | Pain, CancerGermany
-
Universitat Jaume ICompletedPain, Acute | Pain, Chronic | OncologySpain
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Dr. Negrin University HospitalCompletedPostoperative Pain, Acute | Postoperative Pain, ChronicSpain
-
University of Campinas, BrazilCompletedPREGNANCY | LUMBAR BACK PAIN | PELVIC PAIN
-
George Washington UniversityRecruitingCervical Fusion | Pain, Back | Pain, Neck | Myofacial PainUnited States
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Thoracotomy | Postoperative Pain, Acute | Postoperative Pain, ChronicTurkey
-
Janssen Research & Development, LLCCompletedPain, Radiating | Pain, Burning | Pain, Crushing | Pain, Migratory | Pain, SplittingUnited States, France, Spain, Poland, Portugal
Clinical Trials on VR-Biofeedback
-
Children's Hospital Medical Center, CincinnatiCompleted
-
Children's Hospital Medical Center, CincinnatiCompletedPain | Pain, Postoperative | Anxiety PostoperativeUnited States
-
Hadassah Medical OrganizationUnknown
-
Cedars-Sinai Medical CenterAttune Health Research, Inc.; AppliedVR Inc.UnknownRheumatoid Arthritis | Systemic Lupus Erythematosus | Vasculitis | SpondyloarthropathyUnited States
-
Istituto Auxologico ItalianoCompletedGeneralized Anxiety DisorderItaly
-
Emory UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingStroke | Gait, HemiplegicUnited States
-
Vanessa OlbrechtEnrolling by invitation
-
Technische Universität DresdenMichael J. Fox Foundation for Parkinson's Research; University Hospital Carl...CompletedAutonomic Dysfunction | Acute Ischaemic StrokeGermany
-
Klick Inc.Completed
-
L. Eugene ArnoldNational Institute of Mental Health (NIMH); Brain Resource CenterCompletedAttention Deficit Hyperactivity DisorderUnited States